Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion type Assertion NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_head.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion description "[Among these ZAP-70 'outliers,' those with Ig-mutated CLL had clinical features that are uncharacteristic of this CLL subtype: 2 required early treatment and 2 used a mutated VH3-21 gene, an IgVH gene that has been associated with progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_provenance.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion evidence source_evidence_literature NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_provenance.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion SIO_000772 12595313 NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_provenance.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion wasDerivedFrom befree-20150227 NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_provenance.
- NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_assertion wasGeneratedBy ECO_0000203 NP782091.RAROujAN0xQnmeECvL4H7kWrsH0Wzhl3lSoWA_lkMUz3s130_provenance.